Healio Rheumatology Current Issue
The following articles appeared in the print edition of Healio Rheumatology.
Table of Contents
- The Cannabis Frontier: As Medical Cannabis Moves Mainstream, are Rheumatologists Prepared?
-
- Marijuana, Rheumatology and Clinical Equipoise Leonard H. Calabrese, DO
- Virtual RA Forum®: Applying Recent Advances to Improve Quality Care
- FDA Approves Benlysta for Children, Teens With Lupus
- FDA Approves Eticovo, Second Enbrel Biosimilar
- #RheumJC Uses Social Media to Facilitate Discussion
- ACR, Arthritis Foundation Recommend Against Chronic Glucocorticoids in JIA Treatment
- EULAR Recommends Core Data Set to Standardize Giant Cell Arteritis Registries
- EULAR Recommends Hydroxychloroquine in All Patients With Lupus
-
- Higher Physical Activity Levels Linked to 33% Reduced Risk for RA in Women
- Mortality, Health Care Use Higher in Patients With Both Gout, Chronic Kidney Disease
- Patients With PsA, Psoriasis Face Psychosocial Disruption, Harbor Unmet Treatment Expectations
- Program Disseminates Rheumatology Best Practices in Underserved Areas
- Rheumatologists Rarely Prescribe Contraception Despite Concern for Reproductive Care
- Statins Safe, Efficacious in Lowering LDL Cholesterol in RA
- Ultrasound-detected Enthesitis Common in Patients With PsA, Psoriasis
- Vibration Stimulation of External Ear Alleviates Inflammation in RA
-
- CHECK: Obesity Doubles Odds of Patellofemoral OA Within 8 Years
- Dermatology Pearls for the Rheumatologist: Cutaneous Lupus, Dermatomyositis
- Hospital Readmissions Decline, ED Visits Rise for Patients Following Elective OA Surgery
- JAK Inhibitors, Ustekinumab Show Promise in SLE, More Data Needed
- Statins Lowered Joint Replacement Risk in RA, Not OA
- Patients With Both Gout, Chronic Kidney Disease Undertreated
- Self-reported Stiffness Comparable to MRI in Predicting Radiographic Knee OA
- Onsite With Drexel University: Office-based Infusion Center Broadens Patient Access
-
- Dietary Omega-3 Fatty Acids Linked to Lower Risk of Recurrent Gout Flare
- Musculoskeletal Disease Second-highest Global Cause of Years Lived With Disability
- NSAID Efficacy in OA Peaks at 2 Weeks, Wanes Over Time